NO20040364L - Tienopyrimidindioner og deres anvendelse ved modulering av autoimmune sykdommer - Google Patents

Tienopyrimidindioner og deres anvendelse ved modulering av autoimmune sykdommer

Info

Publication number: NO20040364L
Authority: NO; Norway
Prior art keywords: tienopyrimidinediones; autoimmune diseases; modulating autoimmune; modulating; diseases
Prior art date: 2001-07-28

Application number

NO20040364A

Other languages

English (en)

Other versions

NO328713B1 (no

Inventor

Martin Edward Cooper

Anthony Howard Ingall

Rukhsana Tasneem Rasul

Simon David Guile

Rachel Heulwen Reynolds

Original Assignee

Astrazeneca Ab Global Ip

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-28

Filing date

2004-01-27

Publication date

2004-03-29

2004-01-27 Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip

2004-03-29 Publication of NO20040364L publication Critical patent/NO20040364L/no

2010-05-03 Publication of NO328713B1 publication Critical patent/NO328713B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Virology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)

NO20040364A 2001-07-28 2004-01-27 Tienopyrimidindioner, fremgangsmate til fremstilling derav, farmasoytisk sammensetning inneholdende slike, samt deres anvendelse ved terapi NO328713B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0118479.5A GB0118479D0 (en)	2001-07-28	2001-07-28	Novel compounds
PCT/GB2002/003399 WO2003011868A1 (en)	2001-07-28	2002-07-24	Thienopyrimidinediones and their use in the modulation of autoimmune disease

Publications (2)

Publication Number	Publication Date
NO20040364L true NO20040364L (no)	2004-03-29
NO328713B1 NO328713B1 (no)	2010-05-03

Family

ID=9919407

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040364A NO328713B1 (no)	2001-07-28	2004-01-27	Tienopyrimidindioner, fremgangsmate til fremstilling derav, farmasoytisk sammensetning inneholdende slike, samt deres anvendelse ved terapi

Country Status (24)

Country	Link
US (2)	US7384950B2 (no)
EP (1)	EP1414825B9 (no)
JP (1)	JP4456364B2 (no)
KR (1)	KR100897469B1 (no)
CN (1)	CN1324033C (no)
AR (1)	AR038000A1 (no)
AT (1)	ATE374204T1 (no)
AU (1)	AU2002319469B2 (no)
BR (1)	BR0211262A (no)
CA (1)	CA2453274A1 (no)
DE (1)	DE60222671T2 (no)
ES (1)	ES2292784T3 (no)
GB (1)	GB0118479D0 (no)
HU (1)	HUP0402336A3 (no)
IL (2)	IL159785A0 (no)
IS (1)	IS2598B (no)
MX (1)	MXPA04000677A (no)
MY (1)	MY138145A (no)
NO (1)	NO328713B1 (no)
NZ (1)	NZ530495A (no)
PL (1)	PL211351B1 (no)
RU (1)	RU2294937C9 (no)
WO (1)	WO2003011868A1 (no)
ZA (1)	ZA200400574B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9801399D0 (sv)	1998-04-21	1998-04-21	Astra Pharma Prod	Method and apparatus for filling containers
GB0117583D0 (en) *	2001-07-19	2001-09-12	Astrazeneca Ab	Novel compounds
GB0118479D0 (en) *	2001-07-28	2001-09-19	Astrazeneca Ab	Novel compounds
US7718802B2 (en)	2001-08-10	2010-05-18	Palatin Technologies, Inc.	Substituted melanocortin receptor-specific piperazine compounds
US7655658B2 (en)	2001-08-10	2010-02-02	Palatin Technologies, Inc.	Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
US7456184B2 (en)	2003-05-01	2008-11-25	Palatin Technologies Inc.	Melanocortin receptor-specific compounds
WO2003013571A1 (en)	2001-08-10	2003-02-20	Palatin Technologies, Inc.	Peptidomimetics of biologically active metallopeptides
US7732451B2 (en)	2001-08-10	2010-06-08	Palatin Technologies, Inc.	Naphthalene-containing melanocortin receptor-specific small molecule
BR0313078A (pt)	2002-08-06	2005-07-12	Astrazeneca Ab	Composto ou um sal deste farmaceuticamente aceitável, composição farmacêutica, e, uso do composto ou de um sal deste farmaceuticamente aceitável
US6890923B2 (en) *	2002-12-16	2005-05-10	Astrazeneca Ab	Compounds
SE0300119D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
SE0300120D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
US7393854B2 (en) *	2003-01-17	2008-07-01	Astrazeneca Ab	Thienopyrimidinedinones and their use in modulation of autoimmune disease
WO2004080463A1 (en) *	2003-03-10	2004-09-23	Schering Corporation	Heterocyclic kinase inhibitors: methods of use and synthesis
US7727991B2 (en)	2003-05-01	2010-06-01	Palatin Technologies, Inc.	Substituted melanocortin receptor-specific single acyl piperazine compounds
US7968548B2 (en) *	2003-05-01	2011-06-28	Palatin Technologies, Inc.	Melanocortin receptor-specific piperazine compounds with diamine groups
US7727990B2 (en)	2003-05-01	2010-06-01	Palatin Technologies, Inc.	Melanocortin receptor-specific piperazine and keto-piperazine compounds
ES2527118T3 (es)	2003-12-19	2015-01-20	Plexxikon Inc.	Compuestos y procedimientos de desarrollo de moduladores de Ret
US7550602B1 (en)	2004-01-14	2009-06-23	Palatin Technologies, Inc.	Small molecule compositions for sexual dysfunction
US7709484B1 (en)	2004-04-19	2010-05-04	Palatin Technologies, Inc.	Substituted melanocortin receptor-specific piperazine compounds
US7498342B2 (en)	2004-06-17	2009-03-03	Plexxikon, Inc.	Compounds modulating c-kit activity
CA2576168A1 (en) *	2004-08-18	2006-03-02	Merck & Co., Inc.	Mitotic kinesin inhibitors
KR20080027775A (ko)	2005-05-17	2008-03-28	플렉시콘, 인코퍼레이티드	피롤(２,３-ｂ)피리딘 유도체 단백질 키나제 억제제
MY153898A (en)	2005-06-22	2015-04-15	Plexxikon Inc	Compounds and methods for kinase modulation, and indications therefor
US7834017B2 (en)	2006-08-11	2010-11-16	Palatin Technologies, Inc.	Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
WO2008063888A2 (en)	2006-11-22	2008-05-29	Plexxikon, Inc.	Compounds modulating c-fms and/or c-kit activity and uses therefor
RU2341527C1 (ru) *	2007-07-17	2008-12-20	Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия"	Аннелированные азагетероциклы, включающие пиримидиновый фрагмент, способ их получения и ингибиторы pi3k киназ
WO2009012283A1 (en)	2007-07-17	2009-01-22	Plexxikon Inc.	Compounds and methods for kinase modulation, and indications therefor
RU2345996C1 (ru) *	2007-07-17	2009-02-10	Андрей Александрович Иващенко	Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
TW200932218A (en) *	2008-01-22	2009-08-01	Boehringer Ingelheim Int	Substituted amino-benzimidazoles, medicaments comprising said compound, their use and their method of manufacture
US20120178766A1 (en) *	2009-03-23	2012-07-12	Sachin Sundarlal Chaudhari	Furopyrimidinedione derivatives as trpai modulators
JP5511942B2 (ja)	2009-04-03	2014-06-04	エフホフマン−ラロッシュアクチェンゲゼルシャフト	組成物及びその使用
WO2011057022A1 (en)	2009-11-06	2011-05-12	Plexxikon, Inc.	Compounds and methods for kinase modulation, and indications therefor
AU2012214762B2 (en)	2011-02-07	2015-08-13	Plexxikon Inc.	Compounds and methods for kinase modulation, and indications therefor
AR085279A1 (es)	2011-02-21	2013-09-18	Plexxikon Inc	Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
JP5990980B2 (ja) *	2012-04-02	2016-09-14	大日本印刷株式会社	オランザピンの中間体の製造方法
US9150570B2 (en)	2012-05-31	2015-10-06	Plexxikon Inc.	Synthesis of heterocyclic compounds
ES2940119T3 (es)	2018-12-21	2023-05-03	Merck Patent Gmbh	Derivados de alquino disustituidos

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6469014B1 (en) *	1997-05-28	2002-10-22	Astrazeneca Ab	Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy
SE9702001D0 (sv) *	1997-05-28	1997-05-28	Astra Pharma Prod	Novel compounds
BR9813373A (pt)	1997-12-05	2000-10-03	Astrazeneca Uk Ltd	Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
US6232320B1 (en)	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
ES2211161T3 (es) *	1998-08-28	2004-07-01	Astrazeneca Ab	Tieno(2,3-d)pirimidindionas novedosas, procedimiento para su preparacion y uso de las mismas en terapia.
GB0117583D0 (en)	2001-07-19	2001-09-12	Astrazeneca Ab	Novel compounds
GB0118479D0 (en) *	2001-07-28	2001-09-19	Astrazeneca Ab	Novel compounds
SE0300119D0 (sv)	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
US7393854B2 (en) *	2003-01-17	2008-07-01	Astrazeneca Ab	Thienopyrimidinedinones and their use in modulation of autoimmune disease
SE0300120D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds

2001
- 2001-07-28 GB GBGB0118479.5A patent/GB0118479D0/en not_active Ceased
2002
- 2002-07-24 CN CNB028152506A patent/CN1324033C/zh not_active Expired - Fee Related
- 2002-07-24 US US10/483,162 patent/US7384950B2/en not_active Expired - Fee Related
- 2002-07-24 AU AU2002319469A patent/AU2002319469B2/en not_active Ceased
- 2002-07-24 WO PCT/GB2002/003399 patent/WO2003011868A1/en not_active Ceased
- 2002-07-24 ES ES02749055T patent/ES2292784T3/es not_active Expired - Lifetime
- 2002-07-24 PL PL369232A patent/PL211351B1/pl not_active IP Right Cessation
- 2002-07-24 JP JP2003517059A patent/JP4456364B2/ja not_active Expired - Fee Related
- 2002-07-24 MX MXPA04000677A patent/MXPA04000677A/es active IP Right Grant
- 2002-07-24 KR KR1020047001192A patent/KR100897469B1/ko not_active Expired - Fee Related
- 2002-07-24 DE DE60222671T patent/DE60222671T2/de not_active Expired - Lifetime
- 2002-07-24 EP EP02749055A patent/EP1414825B9/en not_active Expired - Lifetime
- 2002-07-24 IL IL15978502A patent/IL159785A0/xx unknown
- 2002-07-24 HU HU0402336A patent/HUP0402336A3/hu unknown
- 2002-07-24 NZ NZ530495A patent/NZ530495A/en not_active IP Right Cessation
- 2002-07-24 CA CA002453274A patent/CA2453274A1/en not_active Abandoned
- 2002-07-24 BR BR0211262-0A patent/BR0211262A/pt not_active IP Right Cessation
- 2002-07-24 RU RU2004102392/04A patent/RU2294937C9/ru not_active IP Right Cessation
- 2002-07-24 AT AT02749055T patent/ATE374204T1/de not_active IP Right Cessation
- 2002-07-26 AR ARP020102842A patent/AR038000A1/es active IP Right Grant
- 2002-07-26 MY MYPI20022835A patent/MY138145A/en unknown
2004
- 2004-01-08 IL IL159785A patent/IL159785A/en not_active IP Right Cessation
- 2004-01-19 IS IS7118A patent/IS2598B/is unknown
- 2004-01-26 ZA ZA200400574A patent/ZA200400574B/en unknown
- 2004-01-27 NO NO20040364A patent/NO328713B1/no not_active IP Right Cessation
2008
- 2008-04-29 US US12/111,792 patent/US20080207642A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2004538316A (ja)	2004-12-24
ZA200400574B (en)	2005-04-26
DE60222671D1 (de)	2007-11-08
PL211351B1 (pl)	2012-05-31
US20080207642A1 (en)	2008-08-28
HUP0402336A3 (en)	2008-09-29
EP1414825B9 (en)	2009-09-16
KR20040017355A (ko)	2004-02-26
NZ530495A (en)	2005-07-29
RU2294937C9 (ru)	2007-07-20
ATE374204T1 (de)	2007-10-15
IS2598B (is)	2010-03-15
AU2002319469B8 (en)	2003-02-17
US20040254198A1 (en)	2004-12-16
ES2292784T3 (es)	2008-03-16
PL369232A1 (en)	2005-04-18
BR0211262A (pt)	2004-07-20
IL159785A0 (en)	2004-06-20
GB0118479D0 (en)	2001-09-19
JP4456364B2 (ja)	2010-04-28
IS7118A (is)	2004-01-19
AR038000A1 (es)	2004-12-22
HUP0402336A2 (hu)	2005-02-28
EP1414825A1 (en)	2004-05-06
RU2004102392A (ru)	2005-07-10
CN1538970A (zh)	2004-10-20
NO328713B1 (no)	2010-05-03
IL159785A (en)	2009-11-18
HK1065785A1 (en)	2005-03-04
WO2003011868A1 (en)	2003-02-13
AU2002319469B2 (en)	2007-08-09
CA2453274A1 (en)	2003-02-13
US7384950B2 (en)	2008-06-10
DE60222671T2 (de)	2008-06-26
RU2294937C2 (ru)	2007-03-10
EP1414825B1 (en)	2007-09-26
MXPA04000677A (es)	2004-04-05
MY138145A (en)	2009-04-30
KR100897469B1 (ko)	2009-05-14
CN1324033C (zh)	2007-07-04

Publication	Publication Date	Title
NO20040364L (no)	2004-03-29	Tienopyrimidindioner og deres anvendelse ved modulering av autoimmune sykdommer
NO20034169D0 (no)	2003-09-19	MCH-antagonister og deres anvendelse ved behandling av fedme
NO20015045D0 (no)	2001-10-17	Diaminotiazoler og deres anvendelse til inhibering av proteinkinaser
DK1404809T3 (da)	2014-03-17	Forbedrede hudsubstitutter og anvendelser deraf
NO20014560D0 (no)	2001-09-19	Quinasoliner og terapautisk anvendelse derav
DK1495053T3 (da)	2012-09-24	Angiopoietin-2 og angiopoietin-1-specifikke bindemidler
NO20021449L (no)	2002-05-07	Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
DK1370128T3 (da)	2014-05-26	Kombineret ballepresse og ballevikler
NO972983L (no)	1997-12-29	Sulfonamider og deres anvendelse
DE60209486D1 (de)	2006-04-27	Pyranoindazole und ihre verwendung in der glaukombehandlung
NO20001323D0 (no)	2000-03-14	Dipeptid-apoptose inhibitorer og deres anvendelse
NO20043370L (no)	2004-09-28	N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer
NO20025357L (no)	2002-11-08	Antranylamider og deres anvendelse som legemidler
ATE456657T1 (de)	2010-02-15	Aromatische methyltransferasen und ihre verwendung
EP1272111A4 (en)	2004-10-06	Omni-actuatable hand-held surgical instruments
DK1511727T3 (da)	2007-06-11	Aromatiske sulfoner og deres medicinske anvendelse
IS6966A (is)	2003-09-24	Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
EP1351388A4 (en)	2009-06-17	PHASE SLIDER AND MULTIBIT PHASE SLIDER
IS6967A (is)	2003-09-24	Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20020031D0 (no)	2002-01-04	Dihydrobenzodiazepiner og deres anvendelse ved behandling av dyslipidemi
DE50202730D1 (de)	2005-05-12	Substituierte isoindole und ihre verwendung
NO20005502D0 (no)	2000-11-01	Polymerer og deres anvendelse
NO20053825D0 (no)	2005-08-15	Thienopyridazinoner og deres anvendelse ved modulering av autoimmune sykdommer.
DK1178981T3 (da)	2003-09-29	Substituerede 3-pyridyl-4-arylpyrroler og deres terapeutiske og profylaktiske anvendelser
NO20030547D0 (no)	2003-02-04	Azabicykliske derivater og deres terapeutiske anvendelse

Legal Events

Date	Code	Title	Description
2013-03-11	MM1K	Lapsed by not paying the annual fees